Latest News | Mankind Pharma Board Approves Up to Rs 10,000 Cr Fundraising Plan

New Delhi, Sep 30 (PTI) Mankind Pharma on Monday said it will raise up to Rs 10,000 crore via issuance of non-convertible debentures and commercial papers.

The company said its board has approved to raise up to Rs 5,000 crore via non-convertible debentures in 3-4 distinct series with maturities of up to 48 months.

Also Read | Stock Market Holidays in October 2024: Know When Stock Market Will Remain Open and Closed for Trading on BSE and NSE.

The board's fundraising committee also approved to raise up to Rs 5,000 crore via listed and rated commercial papers, having face value as may be decided in accordance with applicable law, in one or more tranches or series, the drug maker said in a regulatory filing.

The company, however, did not disclose how it aims to utilise the raised capital.

Also Read | Bank Holidays in October 2024: From Gandhi Jayanti to Navratri, Banks To Remain Closed for 15 Days Next Month; Check Complete List of Bank Holiday Dates.

In July this year, Mankind had announced the acquisition of Bharat Serums and Vaccines from Advent International for around Rs 13,630 crore.

The company is engaged in developing, manufacturing and marketing a diverse range of pharmaceutical formulations and consumer healthcare products.

Shares of the company on Monday ended 2.68 per cent down at Rs 2,521.55 apiece on BSE.

(The above story is verified and authored by Press Trust of India (PTI) staff. PTI, India’s premier news agency, employs more than 400 journalists and 500 stringers to cover almost every district and small town in India.. The views appearing in the above post do not reflect the opinions of LatestLY)